理特咨询（ADL）：2022年未来生命科学报告（英文版）（32页）.pdf

1、TOMORROW S LIFE SCIENCESInsights.Impacts.Imperatives.LIFE SCIENCE REPORT 2022ARTHUR D.LITTLEDR.ULRICA SEHLSTEDTManaging PartnerGlobal Practice Leader,Healthcare&Life SciencesSwedenDR.FRANZISKA THOMASPartner,Head of Healthcare&Life SciencesGermanyCLAUDIA NICHTERLEINManager,Healthcare&Life SciencesGer

2、manyDR.JAMES MILLERManager,Healthcare&Life SciencesGermanyMIN JI KIMConsultant,Healthcare&Life SciencesGermanyMUNICH REANKE IDSTEINChief Executive Life&Health Munich Continental Europe(w/o Iberia,Italy,Malta)and Israel DR.ALBAN SENNChief Medical Officer Life&Health Head of Medical Research&Developme

3、ntDR.MATHIAS ORBANMedical Consultant Life&Health ALEXANDER WIESCHNEWSKISenior Consultant Business Development Life&Health JAKOB WEIGLEINConsultant Business Development Life&Health CONTENTFOREWORD 3EXECUTIVE SUMMARY 41.DIGITAL HEALTH 62.ADVANCED THERAPEUTICS&NEW PARADIGMS IN TREATMENTS 123.POWER OF G

4、ENES&OMICS 164.MENTAL HEALTH 205.PANDEMIC RISK 242Dear reader,We are living in an era of rapid scientific progress.It spans across multiple disciplines and is changing not only the medicines available to patients,but also entire healthcare systems,inclusive of researchers,clinicians,payers,providers

5、,regulatory agencies,and untold numbers of patients.The revolution occurring in healthcare is forcing stakeholders across the industry and all who benefit from healthcare to face a variety of questions:What are the societal implications of these changes?How do they protect health and improve the ind

6、ividuals chance of cure?And how do they affect the business environment for companies in life and health insurance and the life sciences industry?We believe that the magnitude and impact of these discoveries and the current changes across healthcare are so significant that they cannot be adequately